secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0001213900-24-087340
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital Acquisition Corp. extends deadline to Nov 11, 2024 with $15,064 deposit
--------------------------------------------------------------------------------

- Deposited $15,063.74 into trust account to extend deadline one month from Oct 11 to Nov 11, 2024.
- Extension funded via convertible promissory note from Scilex Holding Company (SCLX) with up to $180,000 principal.
- Note bears no interest and is convertible into DECA Class A shares at $10.00/share upon business combination close.
- Remaining $134,835.78 note principal available for future one-month extensions if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024087340/0001213900-24-087340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024087340/ea0217474-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-087340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer